Cargando…

HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial

BACKGROUND: Sustained, routine care is vital to the health of people with HIV (PWH) and decreasing transmission of HIV. We evaluated whether the identification of PWH at-risk of falling out of care and prompts for outreach were effective in retaining PWH in care in the United States. METHODS: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wohlfeiler, Michael B., Weber, Rachel Palmieri, Brunet, Laurence, Fusco, Jennifer S., Uranaka, Christine, Cochran, Quateka, Palma, Monica, Evans, Tammeka, Millner, Carl, Fusco, Gregory P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685944/ https://www.ncbi.nlm.nih.gov/pubmed/36424550 http://dx.doi.org/10.1186/s12875-022-01909-2

Ejemplares similares

1004. Clinical Decision Support System Alerts for HIV Retention in Care – A Pilot Implementation Research Study
por: Leonard, Michael, et al.
Publicado: (2020)

1582. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US: Effectiveness in the First Year
por: Sension, Michael G, et al.
Publicado: (2022)

1608. Real-World Effectiveness of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Treatment-Experienced Individuals: Two Years of Data from the OPERA(®) Cohort
por: Sension, Michael, et al.
Publicado: (2023)

1028. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Findings from the OPERA(®) Cohort
por: Hsu, Ricky K, et al.
Publicado: (2023)

337. Switching from TDF to TAF: Missed Opportunities for Statin Use in HIV
por: Mallon, Patrick, et al.
Publicado: (2019)

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
por: Brunet, Laurence, et al.
Publicado: (2021)

Lipid Changes After Switch From TDF to TAF in the OPERA Cohort: LDL Cholesterol and Triglycerides
por: Mallon, Patrick W G, et al.
Publicado: (2021)

Antiretroviral therapy and liver disorders in the OPERA(®) cohort
por: Wohlfeiler, Michael, et al.
Publicado: (2020)

886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US
por: Pierone, Gerald, et al.
Publicado: (2021)

Weight gain before and after switch from TDF to TAF in a U.S. cohort study
por: Mallon, Patrick WG, et al.
Publicado: (2021)

Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents
por: Mills, Anthony M, et al.
Publicado: (2021)

Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score
por: Hsu, R, et al.
Publicado: (2020)

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study
por: Mills, Anthony M., et al.
Publicado: (2019)

2488. Virologic Failure in ART Naïve Patients Initiating on a Dolutegravir or Elvitegravir-Based Regimen
por: Wohlfeiler, Michael, et al.
Publicado: (2019)

936. Body Fat Redistribution/Accumulation, Pancreatic Disorders, Musculoskeletal Disorders, IRIS, Severe Systemic Rash and Hypersensitivity Reactions Following Initiation of Commonly Prescribed Antiretrovirals
por: Lackey, Philip, et al.
Publicado: (2018)

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice
por: Lackey, Philip, et al.
Publicado: (2016)

1023. Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability
por: Pierone, Gerald, et al.
Publicado: (2023)

1951. Guiding COVID-19 Booster Vaccinations by COVID-19 Quantitative Spike Ig Antibody Titers Regardless of HIV Status, Immunosuppression, and Age
por: Hsu, Ricky K, et al.
Publicado: (2022)

Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens
por: Mounzer, Karam, et al.
Publicado: (2022)

1284. Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens
por: Pierone, Gerald, et al.
Publicado: (2022)

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes
por: Hsu, Ricky K., et al.
Publicado: (2023)

Lessons learned for recruitment and retention of low-income African Americans
por: Taani, Murad H., et al.
Publicado: (2020)

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA(®) observational database: a cohort study
por: Mounzer, Karam, et al.
Publicado: (2019)

341. Risk of Type 2 Diabetes Mellitus after Antiretroviral Therapy Initiation in Individuals Living with HIV in the United States
por: Hsu, Ricky, et al.
Publicado: (2019)

Implementation of dedicated social worker coaching for emergency medicine residents ‐ Lessons learned
por: Buchanan, Jennie A., et al.
Publicado: (2023)

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
por: Mounzer, Karam, et al.
Publicado: (2019)

Lessons from the 1656 Neapolitan Plague: Something to learn for the current coronavirus Pandemic?
por: Bifulco, Maurizio, et al.
Publicado: (2021)

1257. Mental Health, Quality of Life, and Accessibility to Care Among Virally Suppressed People Living with HIV in the United States
por: Evans, Tammeka, et al.
Publicado: (2019)

Validation of the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) chronic kidney disease risk score in HIV‐infected patients in the USA
por: Mills, AM, et al.
Publicado: (2020)

Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype
por: Federico, Antonella, et al.
Publicado: (2014)

Lessons in participant retention in the course of a randomized controlled clinical trial
por: Idoko, Olubukola T, et al.
Publicado: (2014)

Successful adherence and retention to daily monitoring of physical activity: Lessons learned
por: Xu, Xiaomeng, et al.
Publicado: (2018)

Recruitment and Retention in Diverse Cohorts: Lessons From Community-Engaged Efforts
por: Nieman, Carrie, et al.
Publicado: (2021)

Challenges in identifying barriers to adoption in a theory-based implementation study: lessons for future implementation studies
por: Hanbury, Andria, et al.
Publicado: (2012)

Implementation Lessons for Research and Practice
por: Bertram, Rosalyn, et al.
Publicado: (2021)

1550. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women
por: Richmond, Teriya, et al.
Publicado: (2023)

Recruitment and retention of health professionals in the European Union: lessons from country experiences
por: Dussault, Gilles
Publicado: (2014)

Recruitment, retention, and adherence of family caregivers: Lessons from a multisite trial
por: Rueda Díaz, Leidy Johanna, et al.
Publicado: (2023)

Exercise Evaluation and Prescription
por: Foster, Carl, et al.
Publicado: (2021)

Exercise Evaluation and Prescription—Second Edition
por: Foster, Carl, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cr7ma7fs0a0kre8n276rcmkj96